301 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Adicet Bio Funding History

Since Adicet Bio was founded in 2014, it has participated in 5 rounds of funding. In total Adicet Bio has raised $355.0M. Adicet Bio's last funding round was on Jan 2024 for a total of $98.0M.

Adicet Bio Funding Rounds

Unlock 2 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Post-IPO Equity
Jan 2024
$98M
__
Post-IPO Equity
Dec 2021
$100.6M
__
Series B
Jul 2019
$80M
6
Johnson & Johnson Innovation,  aMoon2 Fund,  Samsung Venture Investment Corp,  Orbimed Israel Partners Ltd,  Novartis Venture Fund,  Pontifax Ltd
Series A
Jan 2016
$51M
3
OrbiMed,  Novartis Venture Fund,  Pontifax
Equity
Aug 2015
$25.4M
__

Total Funding: $355M

Adicet Bio Investors

Unlock 5 more investors →

INVESTOR

ROUND

FUNDING DATE

Johnson & Johnson Innovation
Series B
Jul 2019
aMoon2 Fund
Series B
Jul 2019
Samsung Venture Investment Corp
Series B
Jul 2019
Orbimed Israel Partners Ltd
Series B
Jul 2019
Novartis Venture Fund
Series B, Series A
Jul 2019, Jan 2016

Total Investors: 8

Adicet Bio has 8 investors, including Johnson & Johnson Innovation, aMoon2 Fund and Samsung Venture Investment Corp. The latest investment occurred in Jan 2024.